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http://dxObjective: Postoperative hyperglycemia is associated with poor clinical outcomes in patients undergoing car-
diac surgery. However, some experts consider hyperglycemia to be an epiphenomenon related to acute stress. We
investigated whether preoperative patient characteristics can predict hyperglycemia after cardiac surgery in non-
diabetic patients.
Methods: This is a retrospective study of nondiabetic patients undergoing cardiac surgery at a single center dur-
ing the years 2004 to 2009. Hyperglycemia was defined as 2 consecutive blood glucose readings of 150mg/dL or
greater during the 72 hours after cardiac surgery.
Results: This study included 1453 patients with hyperglycemia and 2205 patients without hyperglycemia. Hy-
perglycemic patients were older, were more likely to bemen, had higher bodymass index, were more likely to be
hypertensive and hypercholesterolemic, and had lower left ventricular ejection fractions; in addition, a greater
proportion had a history of cardiovascular disease and renal failure. Multivariate logistic regression analysis
showed age, gender, body mass index, preoperative serum creatinine, left ventricular ejection fraction, previous
cardiac surgery, and preoperative cardiogenic shock to be independently associated with hyperglycemia (P<.05
for all). Hyperglycemic patients had more intraoperative and postoperative complications.
Conclusions: Preoperative patient characteristics are associated with hyperglycemia after cardiac surgery.
(J Thorac Cardiovasc Surg 2013;145:1083-7)P
MPostoperative hyperglycemia after cardiac surgery is associ-
ated with an increased risk of complications, including deep
sternal wound infections, cardiac arrhythmias, and mortal-
ity.1-6 Furnary and colleagues1,7 showed that tight
glycemic control during 72 hours after cardiac surgery
with target blood glucose levels less than 150 mg/dL is
associated with a decrease in mortality and morbidity in
diabetic patients. Similar observations have been reported
in nondiabetic patients.3,6 Therefore, glycemic control
during the 72 hours after cardiac surgery has become
a standard of care. However, there are doubts about the
validity of this approach because no randomized
controlled trials have been conducted. Moreover, some
experts argue that acute illness–related hyperglycemia is
the result of an increase in stress hormones and
proinflammatory cytokines.8-10 Therefore, hyperglycemia
may be an epiphenomenon, and its treatment may not be
necessary. However, a recent study in critically ill
patients showed an association between hyperglycemiae Division of Endocrinology,a Diabetes and Hypertension, and Division of
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The Journal of Thoracic and Carand mortality even after controlling for the severity of
illness.11 We hypothesized that preoperative patient charac-
teristics are associated with postoperative hyperglycemia,
and therefore, postoperative hyperglycemia may not be
purely a stress response.
MATERIALS AND METHODS
This retrospective cohort study included consecutive patients who un-
derwent cardiac surgery at the Brigham and Women’s Hospital between
September 2004 and July 2009. Patients with a known history of diabetes,
preoperative random plasma glucose greater than 200 mg/dL or taking an-
tidiabetic medications, or hemoglobin A1c (HbA1c) greater than 6.5%
were excluded a priori. The project was approved by the Partners Health
Human Research Committee.
Data were extracted from the Cardiac Surgery Database maintained ac-
cording to the definitions of the Society of Thoracic Surgeon’s data stan-
dards, version 2.52.12 Extracted data comprised perioperative parameters,
including age, gender, race, weight, height, smoking status, history of dia-
betes mellitus, hypertension, renal failure, type of cardiac surgery, preop-
erative plasma glucose, preoperative cardiogenic shock, perfusion time
during surgery, number of hours in the intensive care unit (ICU), number
of hours on ventilator support, need for insulin infusion, postsurgical com-
plications, and mortality. According to our clinical protocol, blood glucose
levels are monitored every 1 to 4 hours in all patients undergoing cardiac
surgery for 72 hours postoperatively, and any patient with 2 consecutive
blood glucose values of 150 mg/dL or greater is treated with insulin infu-
sion. Therefore, hyperglycemia was defined as 2 consecutive blood glucose
values of 150 mg/dL or greater.
Statistical Methods
Data were summarized as numbers with percentage, means  standard
deviation, or median with interquartile ranges as appropriate. Chi-square
analyses were used to compare categoric data. Student t test with Levine’s
homogeneity of variance was used to compare normally distributeddiovascular Surgery c Volume 145, Number 4 1083
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Mvariables, and Mann–Whitney U tests were used for non-normally distrib-
uted continuous variables. Risk factors for postoperative hyperglycemia
were evaluated using forward stepwise logistic regression. Preoperative
variables that were statistically different between groups on univariate
analyses and those deemed clinically important were included in the
model; we excluded variables occurring after our group assignment crite-
ria. A final enter method logistic regression was constructed that included
year of surgery to control for changes in our patient comorbidity and clin-
ical practice over time. Interactions were examined but did not substan-
tially improve the final model. Odds ratios are presented per measure
unit for continuous variables. Statistical analyses were done using the
Statistical Package for the Social Sciences version 13.0 (SPSS Inc,
Chicago, Ill).
RESULTS
Of the 3658 patients included in our study, 2205 re-
mained euglycemic and postoperative hyperglycemia de-
veloped in 1453. Differences between the 2 groups are
shown in Table 1. Hyperglycemic patients were older, had
higher body mass index, and were more likely to be men,
hypertensive, and hypercholesterolemic. They were also
more likely to have preexisting renal insufficiency, cardio-
vascular and peripheral vascular disease, and lower left ven-
tricular ejection fraction. A similar proportion of patients
underwent coronary artery bypass surgery or other types
of cardiac surgery. Hyperglycemic patients required longer
extracorporeal perfusion time during surgery. They also re-
quired longer ventilation support and ICU stay, and had
a higher overall complication rate and mortality compared
with the control group.
A logistic regression model was built including the pre-
operative variables from Table 1. Perfusion time, time of
ventilator support, and ICU stay were not included in the
model because these events occurred after assignment to
groups. The results of this analysis are shown in Table 2.
Age, gender, body mass index, serum creatinine, left ven-
tricular ejection fraction, previous cardiac surgery, and pre-
operative cardiogenic shock were independently associated
with hyperglycemia (model performance, 2LL 4894.49;
Cox & Snell R2, 0.060; Nagelkerke R2, 0.082; C-statistic,
0.64; 95% confidence interval, 0.62-0.65; P<.001).
DISCUSSION
Our study shows that many preoperative patient charac-
teristics are independently associated with postoperative
hyperglycemia after cardiac surgery. Postoperative hyper-
glycemia is likely to be the result of an interaction between
preoperative patient characteristics and acute stress. Consis-
tent with previous data, postoperative complications were
more frequent in our hyperglycemic patients. Whether these1084 The Journal of Thoracic and Cardiovascular Surcomplications were due to the presence of preoperative risk
factors or to hyperglycemia itself cannot be determined
from this study. Our data suggest that acute illness–related
hyperglycemia is not an epiphenomenon caused by acute
illness alone.
An association between hyperglycemia and adverse clin-
ical outcomes after cardiac surgery has been known for
some time.13 After the publication of Furnary and col-
leagues’ data,7 treatment of hyperglycemia has generally
been accepted as a standard of care in patients undergoing
cardiac surgery. However, randomized controlled trial data
confirming the effect of glycemic control in these patients
are not available. Randomized controlled trials have been
conducted in critically ill patients. In one of these trials,
62% of the enrolled patients had undergone cardiac sur-
gery.14 This trial showed remarkable benefits from tight gly-
cemic control. However, subsequent clinical trials in
critically ill patients failed to reproduce these results.15,16
The contradictory results of the randomized clinical trials
along with unclear pathogenesis of hyperglycemia in this
setting have created doubts about the validity of tight
glycemic control strategy after cardiac surgery. Our study
suggests that patients in whom hyperglycemia develops
after cardiac surgery are predisposed to develop
hyperglycemia. Therefore, contributors to hyperglycemia
after cardiac surgery are multifactorial and include
preexisting risk factors in addition to the stress of the
surgery and other perioperative events. The same factors
that predispose patients to develop hyperglycemia may
also contribute to their increased morbidity and mortality.
It is difficult to determine from this study whether
hyperglycemia per se is responsible for an increased rate
of complications or whether insulin infusion is useful in
decreasing complications. This study was not designed to
determine the association between hyperglycemia and
complications or the effect of insulin infusion on
complications. It is possible that if hyperglycemic patients
had not received insulin infusion in our cohort,
complication rates would have been higher. Of note, most
recent studies suggest that moderate glycemic control in
a range of 120 to 180 mg/dL is desirable after cardiac
surgery.17,18
One previous study has shown the presence of metabolic
syndrome to be related to hyperglycemia during cardiopul-
monary bypass surgery.19 We did not capture metabolic
syndrome as a discrete diagnosis, but we did find some of
its components to be more prevalent in the hyperglycemic
patients, for example, obesity and dyslipidemia. Another
previous study has shown that the use of angiotensin-
converting enzyme inhibitors is associated with hyperglyce-
mia after cardiac surgery.20 This may be the result of
a higher prevalence of hypertension in the hyperglycemic
group. We did not study the effect of preoperative medica-
tions. Higher preoperative serum creatinine seemed to begery c April 2013
TABLE 1. Patient characteristics
N
All Normoglycemic Hyperglycemic
P 3658 2205 1453
No. (%) of patients by year of surgery
2004 125 33 (26) 92 (74)
2005 757 402 (53.1) 355 (46.9)
2006 794 474 (59.7) 320 (40.3)
2007 715 439 (61.4) 276 (38.6)
2008 798 515 (64.6) 283 (35.4)
2009 469 338 (66.3) 158 (33.7)
Preoperative patient characteristics
Age (y), mean (SD) 64.6 (13.7) 63.3 (14.2) 66.7 (12.8) .001
Age 80 y,% (n) 14.6 (536) 13.5 (298) 16.4 (238) .017
Female% (n) 34.5 (1263) 36.1 (796) 32.1 (467) .014
Not Caucasian race% (n) 6.6 (240) 6.9 (153) 6.0 (87) .175
BMI kg/m2, mean (SD) 27.4 (5.4) 27.2 (5.4) 27.7 (5.2) .010
Random blood glucose mg/dL, mean (SD) 120.9 (24.3) 120.6 (24.0) 121.3 (24.8) .413
Smoker% (n) 49.4 (1806) 48.7 (1073) 50.4 (733) .295
Family history of CAD% (n) 24.6 (900) 24.7 (544) 24.5 (356) .937
Hypercholesterolemia% (n) 64.5 (2358) 62.2 (1372) 67.9 (986) .001
Renal failure% (n) 4.1 (150) 3.4 (75) 5.2 (75) .010
Serum creatinine mg/dL, mean (SD) 1.07 (0.55) 1.06 (0.60) 1.09 (0.48) .123
Hypertension% (n) 37.2 (1360) 35.8 (789) 39.3 (571) .020
Cerebrovascular accident% (n) 4.9 (181) 4.8 (105) 5.2 (76) .534
Peripheral vascular disease% (n) 12.7 (465) 11.3 (249) 14.9 (216) .002
Cerebrovascular disease% (n) 11.2 (408) 10.8 (238) 11.7 (170) .412
Myocardial infarction% (n) 20.1 (736) 18.5 (408) 22.6 (328) .003
Congestive heart failure% (n) 32.4 (1187) 30.2 (667) 35.8 (520) .001
Ejection fraction%, mean (SD) 55.3 (12.3) 56.4 (11.5) 53.7 (13.3) .001
Previous cardiac surgery% (n) 9.4 (344) 8.3 (183) 11.1 (161) .007
Operative characteristics
Perfusion time (min) median (IQR) 117 (89-161) 113 (87-154) 122 (91-171) .001
Crossclamp time (min) median (IQR) 84 (64-114) 84 (64-111) 95 (64-117) .029
CABG% (n) 31.7 (1160) 32.3 (712) 30.8 (448) .364
Valve surgery% (n) 45.2 (1652) 46.4 (1023) 43.3 (629) .067
Valve and CABG% (n) 16.7 (611) 14.4 (318) 20.2 (294) .001
Other surgery% (n) 6.4 (233) 6.8 (150) 5.7 (83) .190
ICU outcomes and complications
Total ICU stay (h), median (IQR) 49.0 (27-84) 47.0 (26-72) 61.0 (31-101) .001
Ventilation time (h), median (IQR) 7.1 (4-12) 6.4 (4-11) 8.5 (5-15) .001
Ventilation>24 h% (n) 9.1 (332) 5.7 (125) 14.3 (207) .001
Reoperation for bleeding% (n) 2.8 (104) 1.6 (36) 4.7 (68) .001
Deep sternal wound infection% (n) 0.6 (23) 0.5 (11) 0.8 (12) .316
Leg infection% (n) 0.6 (22) 0.5 (11) 0.7 (11) .442
Sepsis% (n) 1.8 (64) 1.1 (25) 2.7 (39) .004
Permanent stroke% (n) 3.6 (132) 3.3 (73) 4.0 (59) .386
Pulmonary embolism% (n) 0.4 (16) 0.4 (9) 0.5 (7) 1.000
Limb ischemia% (n) 0.3 (12) 0.2 (5) 0.5 (7) .300
Cardiac arrest% (n) 1.4 (52) 0.8 (17) 2.4 (35) .001
Hospital outcomes
Length of stay (d) median (IQR) 7.0 (5-10) 6.0 (5-10) 7.0 (5-7) .001
Operative mortality% (n) 2.7 (100) 2.2 (48) 3.6 (52) .017
Readmission 30 d% (n) 10.8 (395) 10.6 (235) 11.0 (160) .373
SD, Standard deviation; BMI, body mass index; CAD, coronary artery disease; IQR, interquartile range; CABG, coronary artery bypass grafting; ICU, intensive care unit.
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Mprotective of postoperative hyperglycemia, perhaps because
insulin is partly metabolized by the kidneys. Therefore, pa-
tients with higher serum creatinine levels (lower glomerularThe Journal of Thoracic and Carfiltration rate) may have higher bioavailability of insulin
and lower blood glucose levels. However, this relationship
was broken in patients with renal failure who tended todiovascular Surgery c Volume 145, Number 4 1085
TABLE 2. Logistic regression analysis
P  OR
95.0% CI
Lower Upper
Age (y) .001 1.018 1.012 1.024
BMI .001 1.025 1.012 1.038
Ejection fraction .001 0.988 0.982 0.994
Female gender .002 0.790 0.681 0.917
Preoperative creatinine .045 0.851 0.687 0.968
Cardiogenic shock .010 1.957 1.173 3.264
Previous cardiac surgery .010 1.348 1.074 1.694
Year of surgery (vs 2009) .001
2004 .001 4.811 3.202 7.230
2005 .001 1.526 1.293 1.801
2006 .027 1.216 1.023 1.445
2007 .024 1.250 1.029 1.518
2008 .559 1.074 0.845 1.367
Nonsignificant variables in
the model
Procedure (vs CABG) .096
Valve .967 0.995 0.774 1.278
CABGþvalve .029 0.783 0.629 0.975
Other .275 0.902 0.750 1.085
Hypercholesterolemia .718 1.029 0.881 1.202
Congestive heart failure .053 1.164 0.998 1.356
Preoperative blood glucose .192 1.002 0.999 1.005
Peripheral vascular disease .294 1.115 0.910 1.366
Hypertension .361 0.932 0.800 1.084
Myocardial infarction .771 0.974 0.815 1.163
CI, Confidence interval; OR, odds ratio; BMI, body mass index; CABG, coronary ar-
tery bypass grafting.
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Mhave higher blood glucose levels in our study, possibly sec-
ondary to higher stress levels.Study Limitations
Our study has the limitations expected of any retrospec-
tive data analysis. The year of surgery was included as a sur-
rogate for change in practice, as well as change in
nonspecific patient characteristic over time. Of note, we
found a significant effect of the year of surgery on the inci-
dence of hyperglycemia. This may be attributable to
changes in our clinical practice with regard to hyperglyce-
mia over this time; in particular, patients began receiving in-
sulin infusions during surgery in 2005 and were less likely
to be hyperglycemic when arriving in the ICU postopera-
tively. We think the sudden change from 2004 to 2005
was most likely related to this change in the practice, and
changes in subsequent years were probably related to both
changes in practice and changes in patient characteristics.
Our study includes only 125 patients from 2004. When
we repeated our analysis after excluding these patients,
the results were essentially unchanged. Another limitation
is the possibility of undiagnosed diabetes in our study co-
hort. Although we took all possible precautions to exclude
diabetic patients in this study, some of the patients may still1086 The Journal of Thoracic and Cardiovascular Surhave undiagnosed diabetes because of the high prevalence
of diabetes in patients undergoing cardiac surgery.21 A re-
view of our database revealed that 829 patients (22.6%)
had an HbA1c measured within 3 months preoperatively.
We excluded patients with an HbA1c greater than 6.5%.
Hyperglycemia developed in 728 patients (88%) with avail-
able HbA1c, which was far more than those who did not
have an HbA1c. Because HbA1c testing is not routine at
Brigham and Women’s Hospital, these results likely repre-
sent a testing bias where HbA1c is ordered for patients with
higher risk of diabetes. Therefore, it is unlikely that undiag-
nosed diabetes among patients with no available HbA1c
was a major determinant of hyperglycemia. We believe
our study cohort is representative of the nondiabetic cardiac
surgery patient population.
The results support our hypothesis that preoperative pa-
tient characteristics are associated with postoperative hy-
perglycemia in patients undergoing cardiac surgery.
However, the overall predictive value of the regression
model is rather weak, suggesting that other factors, for ex-
ample, severity of sickness, also may play an important role
in the occurrence of hyperglycemia. Whether these finding
are applicable to other acute illnesses will need further
investigation.
CONCLUSIONS
Preoperative patient characteristics are associated with
postoperative hyperglycemia after cardiac surgery. There-
fore, postoperative hyperglycemia is likely to be a marker
of long-standing abnormalities in these patients, as well
as a response to acute illness.
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